Literature DB >> 3039943

The effects of ultraviolet irradiation of the skin on herpes simplex virus infection: alteration in immune function mediated by epidermal cells and in the course of infection.

T Otani, R Mori.   

Abstract

Previously, we demonstrated that Ia+ epidermal cells (EC) have herpes simplex virus (HSV) antigen-presenting capacity in vitro and play an important role in resistance to HSV infection in vivo. In the present study, we investigated the effects of in vivo ultraviolet (UV) irradiation of the skin on the HSV-immunity function of EC both in vitro and in vivo and on the pathogenesis of HSV infection. Immune T cells cultured with EC and HSV antigen showed a proliferative response in vitro. Exposure of the skin to UV light 1 to 3 days before preparation of EC resulted in dose-dependent impairment of this proliferation. This UV-induced impairment of the accessory cell function of EC was accompanied by a parallel reduction of the number of Ia+ EC. We also transferred these EC-stimulated T cells to intracutaneously infected nude mice. Immune T cells stimulated with EC obtained from irradiated mice did not effectively clear HSV and allowed development of zosteriform skin lesions. In contrast normal-EC-stimulated immune T cells completely prevented the formation of a zosteriform rash. In addition, mice irradiated with UV on shaved midflank skin 2 days before intracutaneous inoculation of HSV showed increased severity of infection and a higher incidence of latency compared with control mice. These studies indicate that in vivo UV irradiation of the skin abrogates the immune function of EC both in vitro and in vivo, and affects HSV pathogenesis. The implication of our results for the better understanding of the effect of UV on acute and recurrent HSV infections is discussed.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3039943     DOI: 10.1007/BF01310986

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  28 in total

1.  Reactivation of herpes simplex virus infection by ultraviolet light and possible involvement of prostaglandins.

Authors:  W A Blyth; T J Hill; H J Field; D A Harbour
Journal:  J Gen Virol       Date:  1976-12       Impact factor: 3.891

2.  Epidermal Langerhans cell density determines whether contact hypersensitivity or unresponsiveness follows skin painting with DNFB.

Authors:  G B Toews; P R Bergstresser; J W Streilein
Journal:  J Immunol       Date:  1980-01       Impact factor: 5.422

3.  Antigen presentation by murine epidermal langerhans cells and its alteration by ultraviolet B light.

Authors:  G Stingl; L A Gazze-Stingl; W Aberer; K Wolff
Journal:  J Immunol       Date:  1981-10       Impact factor: 5.422

4.  Ultraviolet radiation inhibits alloantigen presentation by epidermal cells: partial reversal by the soluble epidermal cell product, epidermal cell-derived thymocyte-activating factor (ETAF).

Authors:  D N Sauder; F P Noonan; E C DeFabo; S I Katz
Journal:  J Invest Dermatol       Date:  1983-06       Impact factor: 8.551

5.  Induction of tolerance to topically applied TNCB using TNP-conjugated ultraviolet light-irradiated epidermal cells.

Authors:  D N Sauder; K Tamaki; A N Moshell; H Fujiwara; S I Katz
Journal:  J Immunol       Date:  1981-07       Impact factor: 5.422

6.  Alterations in epidermal handling of HSV-1 antigens in vitro induced by in vivo exposure to UV-B light.

Authors:  S E Howie; M Norval; J P Maingay
Journal:  Immunology       Date:  1986-02       Impact factor: 7.397

7.  Immunity to herpes simplex virus type 2: viral antigen-presenting capacity of epidermal cells and its impairment by ultraviolet irradiation.

Authors:  Y Hayashi; L Aurelian
Journal:  J Immunol       Date:  1986-02-01       Impact factor: 5.422

8.  Effects of combined use of acyclovir and antibody in athymic nude mice inoculated intracutaneously with herpes simplex virus.

Authors:  M Yamamoto; Y Hayashi; L L Tang; R Mori
Journal:  Antiviral Res       Date:  1985-04       Impact factor: 5.970

9.  Recurrent herpes simplex in the mouse: inflammation in the skin and activation of virus in the ganglia following peripheral stimulation.

Authors:  D A Harbour; T J Hill; W A Blyth
Journal:  J Gen Virol       Date:  1983-07       Impact factor: 3.891

10.  Ultraviolet light depletes surface markers of Langerhans cells.

Authors:  W Aberer; G Schuler; G Stingl; H Hönigsmann; K Wolff
Journal:  J Invest Dermatol       Date:  1981-03       Impact factor: 8.551

View more
  8 in total

1.  The distribution of viral antigens and Langerhans cells during zosteriform spread of herpes simplex virus to the skin of the mouse.

Authors:  N A Williams; C Shimeld; T J Hill
Journal:  Arch Virol       Date:  1992       Impact factor: 2.574

2.  Langerhans cell density and activity in mouse skin and lymph nodes affect herpes simplex type 1 (HSV-1) pathogenicity.

Authors:  E Sprecher; Y Becker
Journal:  Arch Virol       Date:  1989       Impact factor: 2.574

Review 3.  Role of epidermal Langerhans cells in viral infections.

Authors:  E Sprecher; Y Becker
Journal:  Arch Virol       Date:  1988       Impact factor: 2.574

4.  Langerhans cells in vaccinia virus infection in mouse skin.

Authors:  Y Becker; E Sprecher
Journal:  Arch Virol       Date:  1989       Impact factor: 2.574

Review 5.  Role of Langerhans cells and other dendritic cells in viral diseases.

Authors:  E Sprecher; Y Becker
Journal:  Arch Virol       Date:  1993       Impact factor: 2.574

6.  Role of Langerhans cells and Thy. 1+ effector cells in herpes simplex virus-1 infection in the skin of newborn mice.

Authors:  E Sprecher; Y Becker
Journal:  Arch Virol       Date:  1988       Impact factor: 2.574

7.  Herpes simplex virus type 1 infection in mice with severe combined immunodeficiency (SCID).

Authors:  H Minagawa; S Sakuma; S Mohri; R Mori; T Watanabe
Journal:  Arch Virol       Date:  1988       Impact factor: 2.574

8.  Rapid host immune response and viral dynamics in herpes simplex virus-2 infection.

Authors:  Joshua T Schiffer; Lawrence Corey
Journal:  Nat Med       Date:  2013-03       Impact factor: 53.440

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.